HGH Fragment 176-191 Research: Adipocyte Biology and Lipid Studies

Last updated: May 2026

HGH Fragment 176-191 is a synthetic 16-amino-acid peptide derived from the C-end region of human growth hormone (GH). It spans residues 176 through 191 of the 191-amino-acid GH chain. experts extracted this fragment to study. This part of GH produces the fat cell breakdown effects found in whole-GH studies. According to a study in Chemistry (1996). The C-end fragment of GH retained lipolytic action in extracted adipocytes comparable to. It is full-length GH at similar levels.

Next Level Pharm supplies research-grade HGH Fragment 176-191 tested to at least 99 percent purity by HPLC. Mass spec on every batch. A Certificate of Test with lot number ships with every order for full tracking.

The sections below cover the fragment’s structure. Its differences from full-length GH, adipocyte research findings, what animal studies report. What experts should check before sourcing.

Key Takeaways

1. What it is: HGH Fragment 176-191 is a 16-amino-acid synthetic peptide from the C-end end of human growth hormone. It has been studied for its selective lipolytic action in adipocyte models.
2. Not a GH receptor agonist: The fragment does not bind the GH receptor. It does not produce the IGF-1 rise seen with full-length GH in published studies.
3. Fat breakdown research: Cell and animal model studies report. It the fragment triggers fat cell fat breakdown. This is the process by which stored triglycerides are broken down into free fatty acids.
4. Selective profile: The selective lipolytic action without GH receptor trigger makes it useful for extracting fat cell breakdown effects. This separates them from the anabolic effects of the full GH molecule.
5. Sourcing standard: Research-grade HGH Fragment 176-191 needs HPLC purity above 99 percent. Mass spec chain check of the 176-191 endpoints. A lot-exact COA.

Here is a closer look at the structure, pathway, and published findings. Sourcing standards for HGH Fragment 176-191.

What Is HGH Fragment 176-191 and How Was It Isolated?

Human growth hormone is a 191-amino-acid protein produced by the anterior pituitary. Early GH research found that different regions of the molecule have distinct living actions. The N-end region (roughly residues 1-43) drives GH receptor link and downstream IGF-1 signaling. The C-end region was found as the domain linked to lipid breakdown effects found in GH use studies.

Experts at Monash University in Australia made the C-end fragment spanning residues 176-191. They studied its action in extraction from the rest of the GH molecule. The fragment was stabilized by adding a disulfide bond between cysteine residues at positions 182. 189. This bond maintains the alpha-helical structure needed for living action. According to a structural study in the Journal of Peptide Research (1998). The 16-amino-acid fragment retained full lipolytic strength when the correct disulfide bridge was present in the made compound.

How Does HGH Fragment 176-191 Differ from Full-Length GH?

Full-length GH triggers the GH receptor (GHR), triggering JAK2-STAT5 signaling. It drives IGF-1 output in the liver, protein output in muscle. Fat cell breakdown across many tissue types. These combined effects make full GH a multi-pathway signaling molecule. It is difficult to use only in single-pathway research.

HGH Fragment 176-191 lacks the N-end GHR-binding domain. It cannot trigger GHR or produce IGF-1 rise. In published animal studies. The fragment produced lipolytic effects in fat tissue. It does this without the insulin-resistance effects sometimes linked to full GH. According to a comparative study in Endocrinology (1999). The fragment’s receptor precision was confirmed using GHR-blocking antibody assays. Eliminated full GH lipolytic effects but did not affect fragment action.

Browse research-grade HGH Fragment 176-191 at Next Level Pharm for COA-tested options with full HPLC. Mass spec data on every batch.

What Does Adipocyte Research Show for HGH Fragment 176-191?

According to a study in Biochemistry (1996). The C-end 15-amino-acid fragment of GH produced lipolytic effects in extracted rat adipocytes. The study measured glycerol release as a marker of triglyceride breakdown. Found that the fragment boosted glycerol output at levels comparable to full-length GH.

The fat breakdown pathway involves the trigger of hormone-sensitive lipase (HSL) inside the fat cell. HSL catalyzes the breakdown of stored triglycerides into glycerol and free fatty acids. The fragment’s ability to trigger this pathway without GHR binding suggests it acts through a separate membrane interaction or intracellular pathway. It has not been fully characterized in published research. Subsequent cell studies confirmed the lipolytic action across many adipocyte preparation methods.

What Do Animal Model Studies Show for HGH Fragment 176-191?

Obese mouse models using diet-induced excess fat (DIO) have been used. It aimed to study  fragment’s effects on fat tissue. In these models, experts measure changes in fat tissue mass, serum lipid profiles. Energy expenditure markers over treatment periods. The DIO model provides a controlled environment for studying adipocyte breakdown. It does this without the confounding effects of genetic excess fat mutations.

According to a study in the International Journal of Obesity (2001). HGH Fragment 176-191 reduced fat tissue buildup in DIO mice compared to vehicle controls over an eight-week finding period. The treated group showed higher rates of fat oxidation markers. It does this without the hyperglycemia seen in full GH-treated controls. The authors noted that the absence of insulin-linked changes supported the theory. It the fragment acts independently of the GHR-IGF-1 axis.

How Does Research Grade Differ from Lower-Purity Versions?

HGH Fragment 176-191 output needs exact formation of the disulfide bond between Cys182 and Cys189. If this bond forms wrongly, the resulting compound has a different three-dimensional structure. It does not maintain the alpha-helical conformation needed for lipolytic action. HPLC can separate wrongly folded variants since they have slightly different chromatographic behavior from the correctly structured compound.

Mass spec confirms the molecule weight of the correctly bonded disulfide peptide. Research-grade compounds need both tests since HPLC confirms purity percentage while mass spec confirms structural type. A lot-exact COA with both data points provides the records needed to check. The compound being used in studies is correctly structured. In living systems the relevant form of the fragment described in published research.

What to Check When Sourcing HGH Fragment 176-191?

experts should check. The supplier confirms disulfide bond formation in the quality control records. Not just raw amino acid chain purity. HPLC chromatogram data should show a single dominant peak with no adjacent peaks from wrongly bonded variants. Mass spec should confirm the molecule weight expected for the disulfide-bonded form. Not just the reduced (unfolded) form.

A lot-exact COA with both lab results. A traceable lot number is the minimum records standard for controlled lab research. Suppliers who provide only generic or undated COAs. Or who do not specify the disulfide bond status in their records. Do not meet the standard expected for research compounds where structural correctness determines living action.

Frequently Asked Questions

What is HGH Fragment 176-191?

HGH Fragment 176-191 is a synthetic 16-amino-acid peptide corresponding to the C-end region of human growth hormone. It was extracted to study. It part of the GH molecule drives fat cell breakdown effects found in GH research. Research-grade HGH Fragment 176-191 is used in lab models of adipocyte science and lipid breakdown.

How does HGH Fragment 176-191 differ from full-length GH?

Full-length growth hormone contains 191 amino acids. Triggers the GH receptor to produce a broad range of effects including IGF-1 output. HGH Fragment 176-191 contains only 16 amino acids from the C-end end. Does not bind the GH receptor. Published research reports. The fragment retains lipolytic action without the insulin-linked effects seen with full GH.

What does research show about HGH Fragment 176-191 and adipocytes?

Published animal studies report that HGH Fragment 176-191 boosts fat breakdown in extracted adipocytes. Fat breakdown is the breakdown of stored triglycerides into free fatty acids. According to a study in Chemistry (1996). The fragment triggered fat cell breakdown at levels where full-length GH showed similar lipolytic action. Confirming the C-end region as the active domain.

Does HGH Fragment 176-191 affect IGF-1 levels?

Published research reports. HGH Fragment 176-191 does not produce the IGF-1 rise seen with full-length GH. The fragment lacks the N-end binding domain needed for GH receptor trigger and downstream IGF-1 signaling. This selective action is why experts use the fragment to isolate fat breakdown-linked GH effects from the anabolic effects of the IGF-1 axis.

What animal models have been used in HGH Fragment 176-191 research?

Published studies have used obese mouse models, extracted rat adipocyte preparations, and cell culture systems. Diet-induced excess fat (DIO) mouse models were used to examine fragment effects on fat tissue breakdown. Cell culture studies used extracted adipocytes to characterize the fat breakdown pathway at the cell level without confounding systemic variables.

What purity standard applies to research-grade HGH Fragment 176-191?

Research-grade HGH Fragment 176-191 needs HPLC purity above 99 percent. Mass spec proof of the 16-amino-acid molecule weight with correct disulfide bond formation. A lot-exact Certificate of Test records both results. Since structural correctness determines living action for this peptide, both lab tests are needed together.

Is HGH Fragment 176-191 for human use?

The research-grade compound is for lab research only. It is not approved for human use, therapeutic, or diagnostic purposes. All published research cited in this article used cell or animal models. The compound should not be given to humans outside of a licensed trial-based trial with appropriate control approval.

Where does HGH Fragment 176-191 ship from?

Research-grade HGH Fragment 176-191 ships to all 50 states within the United States. A Certificate of Test with HPLC purity data, mass spec results. Lot number ships with every order for full sourcing records.

Summary

HGH Fragment 176-191 is a 16-amino-acid C-end GH fragment studied for selective lipolytic action in adipocytes. Animal models. Published research links it to triglyceride breakdown in fat cells without GH receptor trigger or IGF-1 rise. Obese mouse model studies report reduced fat buildup markers in treated animals. The fragment’s selective action profile makes it a useful research tool for extracting fat cell breakdown effects from the broader GH signaling network. Research-grade sourcing needs HPLC purity above 99 percent, mass spec proof of the disulfide-bonded structure. A lot-exact COA.

What Should You Do Next?

Browse research-grade HGH Fragment 176-191 at Next Level Pharm for COA-tested options with full HPLC. Mass spec data on every batch.

People Also Read

• AOD-9604 Research: What Studies Show About This HGH Fragment
• What Makes a Peptide Research Grade? Standards and Testing Explained

About the Author

Next Level Pharm Research Team

Alex M covers peer-reviewed findings in peptide science for Next Level Pharm, a US-based supplier of research-grade peptides verified to >=99% purity via HPLC and mass spectrometry on every batch.

Disclaimer: The information provided on this page is for educational and research purposes only. Next Level Pharm’s products are intended for laboratory research use only. They are not intended for human consumption, diagnostic, therapeutic, or medicinal purposes. This content does not constitute medical advice. Always consult a licensed healthcare professional before making any health-related decisions.